Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study.

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

(Reuters) - GSK and Pfizer's respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing a rare neurological disorder, the U.S. Food Drug ...

Already competing to bring the first vaccine against respiratory syncytial virus (RSV) to market, Pfizer and GSK are also fighting a patent infringement battle in the courts. Earlier this month ...

Respiratory syncytial virus prefusion F (RSVpreF ... This study was funded by Pfizer. Several authors declared receiving grants and personal fees from Pfizer paid to the institution outside ...

In the throes of winter's yearly round of respiratory virus outbreaks, it pays to remember what Grandma told you.

For most people RSV is like a cold, but for infants and older people it can lead to serious infections. Here's what to know.

Respiratory syncytial virus, or RSV, is a common respiratory ... There are two immunizations recommended for infants, a maternal RSV vaccine (Pfizer's Abrysvo) given during pregnancy or an RSV ...